75 related articles for article (PubMed ID: 38343325)
1. Neoantigen identification: Technological advances and challenges.
Pu T; Peddle A; Zhu J; Tejpar S; Verbandt S
Methods Cell Biol; 2024; 183():265-302. PubMed ID: 38548414
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA as a source of neoantigens for cancer vaccines.
Ren Y; Manoharan T; Liu B; Cheng CZM; En Siew B; Cheong WK; Lee KY; Tan IJ; Lieske B; Tan KK; Chia G
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38508656
[TBL] [Abstract][Full Text] [Related]
3. Breaking the performance ceiling for neoantigen immunogenicity prediction.
O'Brien H; Salm M; Morton LT; Szukszto M; O'Farrell F; Boulton C; Becker PD; Samuels Y; Swanton C; Mansour MR; Reker Hadrup S; Quezada SA
Nat Cancer; 2023 Dec; 4(12):1618-1621. PubMed ID: 38102360
[No Abstract] [Full Text] [Related]
4. Erratum for the Research Article "A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer" by A. M. Miller
Sci Transl Med; 2024 May; 16(746):eadp8153. PubMed ID: 38718137
[No Abstract] [Full Text] [Related]
5. Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction.
O'Brien H; Salm M; Morton LT; Szukszto M; O'Farrell F; Boulton C; Becker PD; Samuels Y; Swanton C; Mansour MR; Reker Hadrup S; Quezada SA
Nat Cancer; 2024 Apr; 5(4):692. PubMed ID: 38622449
[No Abstract] [Full Text] [Related]
6. Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C; de Andrade Krätzig N; Pecoraro M; Lange S; Seifert P; von Frankenberg C; Untch J; Zuleger G; Wilhelm M; Zolg DP; Dreyer FS; Bräunlein E; Engleitner T; Uhrig S; Boxberg M; Steiger K; Slotta-Huspenina J; Ochsenreither S; von Bubnoff N; Bauer S; Boerries M; Jost PJ; Schenck K; Dresing I; Bassermann F; Friess H; Reim D; Grützmann K; Pfütze K; Klink B; Schröck E; Haller B; Kuster B; Mann M; Weichert W; Fröhling S; Rad R; Hiltensperger M; Krackhardt AM
Nat Commun; 2024 Mar; 15(1):2364. PubMed ID: 38491045
[No Abstract] [Full Text] [Related]
7. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
[TBL] [Abstract][Full Text] [Related]
8. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
Picard E; Verschoor CP; Ma GW; Pawelec G
Front Immunol; 2020; 11():369. PubMed ID: 32210966
[TBL] [Abstract][Full Text] [Related]
9. ImmuneMirror: A machine learning-based integrative pipeline and web server for neoantigen prediction.
Chuwdhury GS; Guo Y; Chiang CL; Lam KO; Kam NW; Liu Z; Dai W
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343325
[TBL] [Abstract][Full Text] [Related]
10. Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
Müller M; Huber F; Arnaud M; Kraemer AI; Altimiras ER; Michaux J; Taillandier-Coindard M; Chiffelle J; Murgues B; Gehret T; Auger A; Stevenson BJ; Coukos G; Harari A; Bassani-Sternberg M
Immunity; 2023 Nov; 56(11):2650-2663.e6. PubMed ID: 37816353
[TBL] [Abstract][Full Text] [Related]
11. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
[TBL] [Abstract][Full Text] [Related]
12. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
[TBL] [Abstract][Full Text] [Related]
13. Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.
Li Z; Chen G; Cai Z; Dong X; He L; Qiu L; Zeng Y; Liu X; Liu J
Chin J Cancer Res; 2021 Jun; 33(3):364-378. PubMed ID: 34321833
[TBL] [Abstract][Full Text] [Related]
14. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
[TBL] [Abstract][Full Text] [Related]
15. Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
Hikichi T; Sakamoto M; Harada M; Saito M; Yamane Y; Tokumura K; Nakamura Y
J Hum Genet; 2022 Jul; 67(7):411-419. PubMed ID: 35110673
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
